In view of the role played by the JAK/STAT pathway in autoimmune diseases [98], and the demonstration that filgotinib (a JAK1 inhibitor) suppressed the transcription of ISGs in human salivary gland epithelial cells [99], a growing interest has arisen in the use of kinase inhibitors in pSS. The gene discussed is SOAT1; the disease is autoimmune disease.